Propofol: therapeutic indications and side-effects

Area of Science:

• Anesthesiology and Critical Care Medicine

Background:

• Propofol (2,6-diisopropylphenol) is a key intravenous hypnotic agent for anesthesia and ICU sedation.
• It is formulated as an oil-in-water emulsion containing soybean oil, glycerol, and egg phosphatide.
• Preservatives like disodium edetate (EDTA) or metabisulfite are added to inhibit microbial growth.

Purpose of the Study:

• To provide a comprehensive overview of propofol's properties, applications, and safety profile.
• To highlight propofol's pharmacological actions and therapeutic benefits.
• To discuss potential adverse effects and rare but serious complications.

Main Methods:

• Review of propofol's mechanism of action, including GABA(A) receptor activation and modulation of NMDA receptors and calcium channels.
• Analysis of clinical applications in anesthesia, sedation, and various critical conditions.
• Examination of reported safety data, including common and rare adverse events.

Main Results:

• Propofol exhibits rapid onset and recovery, dose-dependent hypnotic effects, and CNS depression.
• It possesses antioxidant, anti-inflammatory, bronchodilator, anticonvulsant properties, and reduces cerebral oxygen consumption and intracranial pressure.
• Common side effect is dose-dependent hypotension; rare complications include hypertriglyceridemia, pancreatitis, and potentially fatal propofol infusion syndrome.

Conclusions:

• Propofol is a versatile and effective anesthetic and sedative agent with a generally favorable safety profile.
• Its unique pharmacological properties enable its use in diverse clinical scenarios, including traumatic brain injury and status epilepticus.
• Awareness of potential complications, particularly propofol infusion syndrome, is crucial for safe patient management.